(Reuters) -Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ingredient in its popular weight-loss and diabetes medicines. This comes after a U.S. federal judge last month refused to allow compounding pharmacies to keep making copies of these drugs in the United States. Compounders […]
The post Lilly Sues Two Compounders Over Copies Of Weight-loss Drugs first appeared on News Health.
Author : News Health
Publish date : 2025-04-01 13:38:00
Copyright for syndicated content belongs to the linked Source.